Clinical Trial Update: Atezolizumab and Bevacizumab Combination Recommended in a Multidisciplinary Consultation Meeting in Caen for Hepatocellular Carcinoma (ABCHCaen)

View source ↗

Summary

The clinical trial evaluating atezolizumab plus bevacizumab for hepatocellular carcinoma has completed, and the combination was recommended in a multidisciplina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Avastin (bevacizumab)
• Tecentriq (atezolizumab)

Snippet

Sponsor: University Hospital, Caen | Conditions: Atezolizumab and Bevacizumab in Hepatocellular Carcinoma | Status: COMPLETED